BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹45,915 Cr | ₹42,253 Cr | ₹40,574 Cr | ₹39,408 Cr | ₹11,718 Cr |
What is the latest Total Non-Current Assets ratio of BIOCON ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹45,915 Cr |
| Mar2025 | ₹42,253 Cr |
| Mar2024 | ₹40,574 Cr |
| Mar2023 | ₹39,408 Cr |
| Mar2022 | ₹11,718 Cr |
How is Total Non-Current Assets of BIOCON Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹45,915 Cr | 8.67 | |
| Mar2025 | ₹42,253 Cr | 4.14 | |
| Mar2024 | ₹40,574 Cr | 2.96 | |
| Mar2023 | ₹39,408 Cr | 236.29 | |
| Mar2022 | ₹11,718 Cr | - | |
Compare Total Non-Current Assets of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹64,739.8 Cr | -1.9% | -9.2% | 14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -1.9% |
-9.2% |
14% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses